Alisa Lask - 14 Dec 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role: Director
Signature: /s/ Christopher Melsha as attorney-in-fact for Alisa Lask pursuant to power of attorney previously filed.
Issuer symbol: NEPH
Transactions as of: 14 Dec 2021
Transactions value $: $0
Form type: 4
Filing time: 16 Dec 2021, 20:17:32 UTC
Next filing: 12 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NEPH	Common Stock	Award	$0	+4,582	+64%	$0	11,725	14 Dec 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEPH	Stock Option (right to buy)	Award	$0	+7,062		$0	7,062	14 Dec 2021	Common Stock	7,062	$6.82	Direct	F4
holding	NEPH	Stock Option (right to buy)						9,617	14 Dec 2021	Common Stock	9,617	$5.22	Direct	F2
holding	NEPH	Stock Option (right to buy)						5,568	14 Dec 2021	Common Stock	5,568	$8.57	Direct	F2
holding	NEPH	Stock Option (right to buy)						6,850	14 Dec 2021	Common Stock	6,850	$8.06	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for her service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
F2	Fully exercisable.
F3	This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.
F4	Represents options granted to the reporting person for her service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.